Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma.

Sauter CS, Senechal B, Rivière I, Ni A, Bernal Y, Wang X, Purdon T, Hall M, Singh AN, Szenes VZ, Yoo S, Dogan A, Wang Y, Moskowitz CH, Giralt S, Matasar MJ, Perales MA, Curran KJ, Park J, Sadelain M, Brentjens RJ.

Blood. 2019 Aug 15;134(7):626-635. doi: 10.1182/blood.2018883421. Epub 2019 Jul 1.

PMID:
31262783
2.

BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy.

Smith EL, Mailankody S, Staehr M, Wang X, Senechal B, Purdon TJ, Daniyan AF, Geyer MB, Goldberg AD, Mead E, Santomasso BD, Landa J, Rimner A, Riviere I, Landgren O, Brentjens RJ.

Cancer Immunol Res. 2019 Jul;7(7):1047-1053. doi: 10.1158/2326-6066.CIR-18-0551. Epub 2019 May 21.

PMID:
31113804
3.

Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL.

Geyer MB, Rivière I, Sénéchal B, Wang X, Wang Y, Purdon TJ, Hsu M, Devlin SM, Palomba ML, Halton E, Bernal Y, van Leeuwen DG, Sadelain M, Park JH, Brentjens RJ.

JCI Insight. 2019 Apr 2;5. pii: 122627. doi: 10.1172/jci.insight.122627.

4.

Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy.

Geyer MB, Rivière I, Sénéchal B, Wang X, Wang Y, Purdon TJ, Hsu M, Devlin SM, Halton E, Lamanna N, Rademaker J, Sadelain M, Brentjens RJ, Park JH.

Mol Ther. 2018 Aug 1;26(8):1896-1905. doi: 10.1016/j.ymthe.2018.05.018. Epub 2018 Jun 15.

5.

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.

Santomasso BD, Park JH, Salloum D, Riviere I, Flynn J, Mead E, Halton E, Wang X, Senechal B, Purdon T, Cross JR, Liu H, Vachha B, Chen X, DeAngelis LM, Li D, Bernal Y, Gonen M, Wendel HG, Sadelain M, Brentjens RJ.

Cancer Discov. 2018 Aug;8(8):958-971. doi: 10.1158/2159-8290.CD-17-1319. Epub 2018 Jun 7.

6.

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.

Park JH, Rivière I, Gonen M, Wang X, Sénéchal B, Curran KJ, Sauter C, Wang Y, Santomasso B, Mead E, Roshal M, Maslak P, Davila M, Brentjens RJ, Sadelain M.

N Engl J Med. 2018 Feb 1;378(5):449-459. doi: 10.1056/NEJMoa1709919.

7.

Results of cytomegalovirus DNA viral loads expressed in copies per millilitre and international units per millilitre are equivalent.

Dimech W, Cabuang LM, Grunert HP, Lindig V, James V, Senechal B, Vincini GA, Zeichhardt H.

J Virol Methods. 2018 Feb;252:15-23. doi: 10.1016/j.jviromet.2017.11.001. Epub 2017 Nov 7.

PMID:
29126838
8.

Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells.

Geyer MB, Manjunath SH, Evans AG, Park JH, Davila ML, Cutler CS, Wang X, Wang Y, Senechal B, Rivière I, Sadelain M, Liesveld JL, Brentjens RJ.

Leuk Lymphoma. 2018 Jul;59(7):1717-1721. doi: 10.1080/10428194.2017.1390237. Epub 2017 Oct 18. No abstract available.

9.

Ten years of external quality assessment of human immunodeficiency virus type 1 RNA quantification.

Senechal B, James VL.

J Clin Microbiol. 2012 Nov;50(11):3614-9. doi: 10.1128/JCM.01221-12. Epub 2012 Sep 5.

10.

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.

Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, Jais JP, D'Cruz D, Casanova JL, Trouillet C, Geissmann F.

Immunity. 2010 Sep 24;33(3):375-86. doi: 10.1016/j.immuni.2010.08.012. Epub 2010 Sep 9.

11.

CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation.

Auffray C, Fogg DK, Narni-Mancinelli E, Senechal B, Trouillet C, Saederup N, Leemput J, Bigot K, Campisi L, Abitbol M, Molina T, Charo I, Hume DA, Cumano A, Lauvau G, Geissmann F.

J Exp Med. 2009 Mar 16;206(3):595-606. doi: 10.1084/jem.20081385. Epub 2009 Mar 9.

12.

Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis.

Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P, Glorion C, Mansuy L, Gaudelus J, Debre M, Jaubert F, Seigneurin JM, Thomas C, Joab I, Donadieu J, Geissmann F.

PLoS One. 2008 Sep 23;3(9):e3262. doi: 10.1371/journal.pone.0003262.

13.

Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.

Senechal B, Elain G, Jeziorski E, Grondin V, Patey-Mariaud de Serre N, Jaubert F, Beldjord K, Lellouch A, Glorion C, Zerah M, Mary P, Barkaoui M, Emile JF, Boccon-Gibod L, Josset P, Debré M, Fischer A, Donadieu J, Geissmann F.

PLoS Med. 2007 Aug;4(8):e253.

14.

Herpes simplex virus encephalitis in human UNC-93B deficiency.

Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Sénéchal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Héron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova JL.

Science. 2006 Oct 13;314(5797):308-12. Epub 2006 Sep 14.

15.

X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, Frucht DM, Christel K, von Bernuth H, Jouanguy E, Feinberg J, Durandy A, Senechal B, Chapgier A, Vogt G, de Beaucoudrey L, Fieschi C, Picard C, Garfa M, Chemli J, Bejaoui M, Tsolia MN, Kutukculer N, Plebani A, Notarangelo L, Bodemer C, Geissmann F, Israël A, Véron M, Knackstedt M, Barbouche R, Abel L, Magdorf K, Gendrel D, Agou F, Holland SM, Casanova JL.

J Exp Med. 2006 Jul 10;203(7):1745-59. Epub 2006 Jul 3.

16.

The class 6 semaphorin SEMA6A is induced by interferon-gamma and defines an activation status of langerhans cells observed in pathological situations.

Gautier G, de Saint-Vis B, Sénéchal B, Pin JJ, Bates EE, Caux C, Geissmann F, Garrone P.

Am J Pathol. 2006 Feb;168(2):453-65.

17.

Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses.

Yang K, Puel A, Zhang S, Eidenschenk C, Ku CL, Casrouge A, Picard C, von Bernuth H, Senechal B, Plancoulaine S, Al-Hajjar S, Al-Ghonaium A, Maródi L, Davidson D, Speert D, Roifman C, Garty BZ, Ozinsky A, Barrat FJ, Coffman RL, Miller RL, Li X, Lebon P, Rodriguez-Gallego C, Chapel H, Geissmann F, Jouanguy E, Casanova JL.

Immunity. 2005 Nov;23(5):465-78.

18.

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

Sénéchal B, Boruchov AM, Reagan JL, Hart DN, Young JW.

Blood. 2004 Jun 1;103(11):4207-15. Epub 2004 Feb 12.

PMID:
14962896
19.

Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy.

Mazeron MC, Fillet AM, Salmon D, Boukli N, Houhou N, Sénéchal B, Matheron S, Gozlan J, Leport C, Katlama C, Scieux C, Imbert BM, Deny P, Bour JB, Freymuth F, Chanzy B, Chaput S, Costagliola D; Predivir Study Group.

AIDS. 2003 Mar 28;17(5):784-6. No abstract available.

PMID:
12646814
20.

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.

Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C; RESTIMOP study team.

AIDS. 2001 Jan 5;15(1):23-31.

PMID:
11192865
21.

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.

Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D.

AIDS. 2000 May 26;14(8):1041-9.

PMID:
10853987
22.

Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication.

Movassagh M, Gozlan J, Senechal B, Baillou C, Petit JC, Lemoine FM.

Blood. 1996 Aug 15;88(4):1277-83.

PMID:
8695845
23.

[Esthetic rhinoplasty in the elderly].

Sénéchal G, Sénéchal B.

Ann Chir Plast Esthet. 1991;36(1):79-81. French.

PMID:
1712172
24.

[Rhinoplasty in the elderly].

Senechal G, Senechal B.

Rev Laryngol Otol Rhinol (Bord). 1989;110(1):97-9. French.

PMID:
2491726
25.

[For or against rhinoplasty in children?].

Sénéchal G, Sénéchal B.

Ann Chir Plast Esthet. 1989;34(5):439-42. French.

PMID:
2480739
26.

[A controversial procedure: rhinoplasty in children].

Sénéchal G, Sénéchal B, Soudant J, Lamas G.

Ann Otolaryngol Chir Cervicofac. 1988;105(4):265-70. French.

PMID:
3408098
27.

[Treatment of acquired stenoses of the external auditory canal. Value of pedicle flaps].

Sénéchal G, Lamas G, Soudant J, Sénéchal B.

Ann Chir Plast Esthet. 1988;33(4):342-6. French. No abstract available.

PMID:
2465722
28.

[Otoplasties].

Senechal G, Senechal B.

J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1983 Jun;32(6):378-83. French. No abstract available.

PMID:
6224913
29.

[Injuries of the nose in the newborn and young infant].

Sénéchal B, Sauvi G, Sénéchal G.

Ann Otolaryngol Chir Cervicofac. 1983;100(8):593-7. French.

PMID:
6670811
30.

[Riedel's thyroiditis. Apropos of a case with acute massive fibrous development].

Contencin P, Sénéchal B, Sénéchal G.

Ann Otolaryngol Chir Cervicofac. 1983;100(7):527-31. French.

PMID:
6638777
31.

[Rare tumor of the cavum (mycosis fungoides)].

Sénéchal G, Chomette G, Sénéchal B, Adjamagbo H, Brami S, Contencin P.

Ann Otolaryngol Chir Cervicofac. 1983;100(7):519-21. French.

PMID:
6638775
32.

[Complications and failures of otoplasty].

Sénéchal B, Chauffeté JP, Sénéchal G.

Ann Otolaryngol Chir Cervicofac. 1983;100(7):493-8. French.

PMID:
6638771
33.

[Critical study of corrective technics for protuding ears].

Sénéchal G, Sénéchal B.

Ann Otolaryngol Chir Cervicofac. 1983;100(6):451-4. French. No abstract available.

PMID:
6625433
34.

[Lethal midline granuloma of unknown cause: 6 new cases and review of the literature].

Cabane J, Dubernet T, Chomette G, Godeau P, Auriol M, Vaillant JM, Sénéchal B.

Biomed Pharmacother. 1982;36(10):426-36. French.

PMID:
7184514
35.

[Palliative surgery for facial paralysis].

Sénéchal G, Sénéchal B, Contancin P.

Ann Otolaryngol Chir Cervicofac. 1982;99(7-8):313-5. French.

PMID:
7137774
36.

[Facial diplegia. A necessary palliative intervention].

Sénéchal G, Sénéchal B.

Ann Chir Plast. 1982;27(4):394-5. French. No abstract available.

PMID:
6186180
37.

[Palliative treatment of bilateral facial paralysis].

Sénéchal G, Sénéchal B, Chauffete JP.

Ann Otolaryngol Chir Cervicofac. 1982;99(7-8):317. French. No abstract available.

PMID:
6182831
38.

[Two concrete cases of deafness].

Sénéchal B.

Soins. 1981 Mar 5;26(5):37-9. French. No abstract available.

PMID:
6910248
39.

[A rare and late complication of rhinoplasties (author's transl)].

Senechal G, Senechal B, Mamelle G.

Ann Otolaryngol Chir Cervicofac. 1981;98(7-8):385-6. French.

PMID:
7340676
40.

[Reflections concerning the reconstruction of the pinna of the ear (author's transl)].

Senechal G, Mamelle G, Rodriguez J, Senechal B.

Ann Otolaryngol Chir Cervicofac. 1981;98(7-8):367-70. French.

PMID:
7340673
41.

[The value of fibroscopy in laryngotracheal stenosis (author's transl)].

Freyss G, Garbi N, Senechal B, Brasnu D, Lacombe H.

Ann Otolaryngol Chir Cervicofac. 1980 Sep;97(9):657-63. French.

PMID:
7458123
42.

[Compound grafts in laryngeal operations (author's transl)].

Senechal G, Senechal B.

Ann Chir Plast. 1978;23(4):241-2. French. No abstract available.

PMID:
384890

Supplemental Content

Loading ...
Support Center